Bevacizumab and Interleukin-2 in Treating Patients With Metastatic Kidney Cancer

NCT00301990 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

65

Enrollment

OTHER

Sponsor class

Conditions

Kidney Cancer

Interventions

BIOLOGICAL: aldesleukin
BIOLOGICAL: bevacizumab

Sponsor

Jonsson Comprehensive Cancer Center

Collaborators

[object Object]